Market access
Experts addressed different possible models for optimising data collection to support the...
How do you prove the lifetime benefits of a potentially life-altering one-off therapy through...
In previous work, we have shown that outcomes-based reimbursement (OBR), whereby payments to...
In previous work, we have shown that outcomes-based reimbursement (OBR), whereby payments to...
Outcomes-based managed entry agreements (MEAs) can enable patient access to promising high cost...
The HE&MA function of the CGT Catapult engaged with an ATMP developer to identify the US...
A key challenge for the commercial viability of ATMPs is achieving both a high price and...
Understanding how price, revenue and profit margins can be maximised is key to any commercial...